Tải bản đầy đủ (.ppt) (19 trang)

Tài liệu Influenza A (H5N1): Prevention pptx

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (67.46 KB, 19 trang )

Influenza A (H5N1):
Prevention
Prof. Nguyen Duc Hien, MD, PhD
Director of NIITD, Vietnam
Introduction

Prevention of Infectious diseases

Measures

Vaccines/antiserum

Standard/universal precautions

Personal protective equipments

Prophylatic medications

Quarantine and isolation
Introduction

Prevention of Infectious diseases

Levels

In hospital

Close contacts

Community


Pandemics
Introduction

Prevention of Infectious diseases

Functions of:

Healthcare workers

Clinicians

Grassroot healthcare workers

Epidemiologists

Household members

Policy makers
Influenza A (H5N1)

Etiology: virus

Effectiveness of antivirals

Oseltamivir, zanamivir

Amantadine (?), Rimantadine (?)

Transmission


Route

Respiratory tract

Gastrointestinal tract

Methods

Droplets

Airborne (?)
Influenza A (H5N1)

Risk factors

A match case-control study from NIHE 2006

Design

28 case-patients

106 control-respondents

Results

Preparing sick/dead poultry ≤ 7 days before illness onset

Having sick/dead poultry in the household ≤ 7 days
before illness onset


Lack of an indoor water source

No clear evidence of human-human
transmission
Control Influenza A (H5N1)

Prerequisite

Control avian influenza in poultry

Vaccines

Early detecting poultry cases

Localizing outbreak areas

Destroying suspected poultry flocks

Future: centralization in raising/slautering

Control poultry-human contacts

Propagation/Health education

Symptomatic surveillance

Prophylaxis for poultry workers and household
members (?)

Oseltamivir 75 mg qd

Prevention: Vaccines

H5N1 vaccine: in studying

Yearly vaccine production

Antigen: H1N1, H3N2 and influenza B

Influenza antigen: shift and drift

Require yearly data from global influenza surveillance

Rate of vaccine failure ?

Type of Influenza vaccine

Killed vaccines

Live vaccines
Prevention: Vaccines

Recomendation

Groups to target FLU-A

Facilities

Likelihood of transmission to high risk persons

Underlying medical conditions


Age > 65 years/6-23 months

Poultry workers ???

Guidelines from WHO, CDC

Priority in pandemic situation ?
“If the pandemic were to start now,
we would have to rely on non-
vaccine measures for atleast 6
months Vaccines may only be
available for the second wave of
the pandemic Starting
preparation now is essential”
“Our goal should be to develop a
new cell culture-based vaccine that
includes antigens that are present in
all subtypes of influenza virus. that
do not change from year to year,
and that can be made available to
the entire world population”
(Osterholm, NEJM 2005)
Prevention: Standard/Universal
precautions

Simple but important measures

Must be applied to all patients receiving
care in hospitals


Require strengthening education for
healthcare workers

Developping countries:

Health education for patients’ ralatives
Prevention: personal protective
equipment

High-efficiency mask

European CE approved respirators

US NIOSH certified N-95

Gown

Face shield/google

Gloves
Prevention: prophylactic
medications

Medication

Oseltamivir 75 mg qd

In hospital


Close contacts without protective equipments

Patient’s ralatives

Healthcare workers

Community

Poultry workers contact with H5N1 poultry

Household members of H5N1 cases
Prevention: prophylactic
medications

Shortcoming issues

Stockpile:

How many courses and for how long

Strategies for drug turning over

Duration of prophylactic treatment

7 days ?

As long as 7 days after last contacts ?

Side effects ?


In outbreak areas

Oseltamivir must be given all population in the area that have
the first human H5N1 cases ?
Prevention: quarantine and
isolation

Manage suspected cases in seperated
room

Negative pressure room

Waste disposal inside

Each room has a buffer room

Patient beds

More than 1 m apart

Seperated by a physical barrier
Prevention: quarantine and
isolation

Limit the number of

Healthcare workers who have direct contact with the
patients

They should not look after other patients


Other hospital employees with access to the
environment of these patients

Cleaners

Laboratory personnel

Visitors

Provide them with appropriate personal protective equipment
and instruct them in its use
Prevention: quarantine and
isolation

Monitor body temperature and other symptoms
for 7 (or 14 ?) days after the last exposure:

Close contacts

Heathcare workers

Who have a fever > 38
0
C and who have had direct patient
contact should be treated immediately

All preventive measures for patients remain in
place after resolution of the fever.


Adults: for 7 days

Children: for 21 days
THANK YOU FOR
YOUR ATTENTION

×